Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | 2C29H29N3O3S.C4H4O4 |
| Molecular Weight | 1115.32 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 1 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OC(=O)\C=C\C(O)=O.CC(C)(CC1=CC=C(OC2=NC=CC=C2C#N)C=C1)NC[C@H](O)COC3=CC=CC=C3C4=CC=CS4.CC(C)(CC5=CC=C(OC6=NC=CC=C6C#N)C=C5)NC[C@H](O)COC7=CC=CC=C7C8=CC=CS8
InChI
InChIKey=MEEKSPBNXICJNQ-CXUXXADZSA-N
InChI=1S/2C29H29N3O3S.C4H4O4/c2*1-29(2,17-21-11-13-24(14-12-21)35-28-22(18-30)7-5-15-31-28)32-19-23(33)20-34-26-9-4-3-8-25(26)27-10-6-16-36-27;5-3(6)1-2-4(7)8/h2*3-16,23,32-33H,17,19-20H2,1-2H3;1-2H,(H,5,6)(H,7,8)/b;;2-1+/t2*23-;/m00./s1
Lubabegron was initially studied in the Eli Lilly’s lab for potential applications in human health. The drug is a beta-adrenergic agonist that has the effect of increasing the breakdown of fats and increasing energy expenditure in cells. Lubabegron is the first animal drug that was approved to reduce ammonia gas emissions from an animal or its waste. These ammonia gasses can come from many sources and can affect the health of people, animals and the environment.
Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
391926-19-5
Created by
admin on Mon Mar 31 21:24:41 GMT 2025 , Edited by admin on Mon Mar 31 21:24:41 GMT 2025
|
PRIMARY | |||
|
35441865UU
Created by
admin on Mon Mar 31 21:24:41 GMT 2025 , Edited by admin on Mon Mar 31 21:24:41 GMT 2025
|
PRIMARY | |||
|
ZZ-88
Created by
admin on Mon Mar 31 21:24:41 GMT 2025 , Edited by admin on Mon Mar 31 21:24:41 GMT 2025
|
PRIMARY | |||
|
71587727
Created by
admin on Mon Mar 31 21:24:41 GMT 2025 , Edited by admin on Mon Mar 31 21:24:41 GMT 2025
|
PRIMARY | |||
|
C166639
Created by
admin on Mon Mar 31 21:24:41 GMT 2025 , Edited by admin on Mon Mar 31 21:24:41 GMT 2025
|
PRIMARY | |||
|
300000044513
Created by
admin on Mon Mar 31 21:24:41 GMT 2025 , Edited by admin on Mon Mar 31 21:24:41 GMT 2025
|
PRIMARY | |||
|
CHEMBL2364615
Created by
admin on Mon Mar 31 21:24:41 GMT 2025 , Edited by admin on Mon Mar 31 21:24:41 GMT 2025
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD